Effect of liposomes and niosomes on skin permeation of enoxacin

被引:221
作者
Fang, JY
Hong, CT
Chiu, WT
Wang, YY
机构
[1] Taipei Med Univ, Grad Inst Pharmaceut Sci, Taipei, Taiwan
[2] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurol, Taipei, Taiwan
[3] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan
[4] Mackay Mem Hosp, Dept Pharmaceut, Taipei, Taiwan
关键词
enoxacin; liposomes; niosomes; skin permeatiom;
D O I
10.1016/S0378-5173(01)00627-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin permeation and partitioning of a fluorinated quinolone antibacterial agent, enoxacin, in liposomes and niosomes, after topical application, were elucidated in the present study. In vitro percutaneous absorption experiments were performed on nude mouse skin with Franz diffusion cells. The influence of vesicles on the physicochemical property and stability of the formulations were measured. The enhanced delivery across the skin of liposome and niosome encapsulated enoxacin had been observed after selecting the appropriate formulations. The optimized formulations could also reserve a large amount of enoxacin in the skin. A significant relationship between skin permeation and the cumulative amount of enoxacin in the skin was observed. Both permeation enhancer effect and direct vesicle fusion with stratum corneum may contribute to the permeation of enoxacin across skin. Formulation with niosomes demonstrated a higher stability after 48 h incubation compared to liposomes. The inclusion of cholesterol improved the stability of enoxacin liposomes according to the results from encapsulation and turbidity. However, adding negative charges reduced the stability of niosomes. The ability of liposomes and niosomes to modulate drug delivery without significant toxicity makes the two vesicles useful to formulate topical enoxacin. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:61 / 72
页数:12
相关论文
共 30 条
[1]   Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles [J].
Carafa, M ;
Santucci, E ;
Alhaique, F ;
Coviello, T ;
Murtas, E ;
Riccieri, FM ;
Lucania, G ;
Torrisi, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) :51-59
[2]   Development and evaluation on transdermal delivery of enoxacin via chemical enhancers and physical iontophoresis [J].
Fang, JY ;
Lin, HH ;
Chen, HI ;
Tsai, YH .
JOURNAL OF CONTROLLED RELEASE, 1998, 54 (03) :293-304
[3]  
Fang JY, 1997, CHEM PHARM BULL, V45, P1504
[4]   DENSITY-BASED SEPARATION OF LIPOSOMES BY GLYCEROL GRADIENT CENTRIFUGATION [J].
GOORMAGHTIGH, E ;
SCARBOROUGH, GA .
ANALYTICAL BIOCHEMISTRY, 1986, 159 (01) :122-131
[5]  
HANDA T, 1987, CHEM PHARM BULL, V35, P748
[6]  
HAZEMOTO N, 1993, CHEM PHARM BULL, V41, P1003
[7]   ENOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
HENWOOD, JM ;
MONK, JP .
DRUGS, 1988, 36 (01) :32-66
[8]  
ISHIHARA H, 1991, CHEM PHARM BULL, V39, P1536
[9]   USE OF LIPID DISPERSE SYSTEMS IN TRANSDERMAL DRUG DELIVERY - COMPARATIVE-STUDY OF FLUFENAMIC ACID PERMEATION AMONG RAT ABDOMINAL SKIN, SILICON RUBBER MEMBRANE AND STRATUM-CORNEUM SHEET ISOLATED FROM HAMSTER-CHEEK POUCH [J].
KUROSAKI, Y ;
NAGAHARA, N ;
TANIZAWA, T ;
NISHIMURA, H ;
NAKAYAMA, T ;
KIMURA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 67 (01) :1-9
[10]   The preparation of norfloxacin-loaded liposomes and their in-vitro evaluation in pig's eye [J].
Lin, HH ;
Ko, SM ;
Hsu, LR ;
Tsai, YH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (08) :801-805